Merck is nearing a $10 billion deal to buy lung diseases focussed Verona Pharma, as the U.S. drugmaker is eyeing deals to ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

A new study that found high levels of heavy metals in popular nicotine vapes adds to concerns about the products.

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...

Oncology Research Program (ORP) today announced new funding for advancing clinical research in Non-Small Cell Lung Cancers ...

Kasing Lung is the creative mind behind the beloved Labubu figures, blending playful storytelling and street art to capture the hearts of toy and art collectors worldwide.

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

With this landmark complex surgery, two patients have now successfully undergone robotic lung transplants, marking a major ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...